IsoRay, Inc. Reports Success In Brain Cancer Treatment, Shares Up Sharply

Shares of IsoRay, Inc. ISR were higher by 30 percent Tuesday morning following news of early success for its Cesium-131 treatment for inoperable brain cancer.

In March 2014, a seven-year-old Peruvian girl was diagnosed with brain cancer, with a tumor located very close to the brain stem, making surgical removal impossible.

A custom Cesium-131 implant was designed and manufactured for placement directly into the tumor, which was implanted in July.

With the radiation treatment now nearly complete, an MRI shows a 70 percent reduction in the mass of the tumor. The girl has now returned to school without any special needs and is back to her normal activities.

Shares of IsoRay, Inc. were higher by 30.4 percent at $1.80.